These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16305066)

  • 1. Diabetes mellitus and vascular risk: continuing the quest for the elusive keystone.
    Marso SP
    Diab Vasc Dis Res; 2005 Feb; 2(1):7-8. PubMed ID: 16305066
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathobiology and cell interactions of platelets in diabetes.
    Stratmann B; Tschoepe D
    Diab Vasc Dis Res; 2005 Feb; 2(1):16-23. PubMed ID: 16305068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus.
    Colwell JA
    Metabolism; 1992 May; 41(5 Suppl 1):7-10. PubMed ID: 1574016
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
    Mathewkutty S; McGuire DK
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications.
    Schneider DJ
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S35-41. PubMed ID: 17917620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proinflammatory and hypercoagulable state of diabetes mellitus.
    Aras R; Sowers JR; Arora R
    Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiology patient page. Platelets and cardiovascular disease.
    Gregg D; Goldschmidt-Clermont PJ
    Circulation; 2003 Sep; 108(13):e88-90. PubMed ID: 14517153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombocyte inhibitors in cardiovascular therapy].
    Lüscher TF; Pfisterer M
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1132-41. PubMed ID: 2218249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets and cardiovascular risk.
    Renga B; Scavizzi F
    Acta Cardiol; 2017 Feb; 72(1):2-8. PubMed ID: 28597734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 13. Introducing the 2019 ESC Guidelines on Diabetes, Pre-Diabetes, and CVD.
    Aboyans V
    Eur Heart J; 2019 Oct; 40(39):3217-3219. PubMed ID: 31608953
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
    Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
    J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients.
    Crescente M; Di Castelnuovo A; Iacoviello L; de Gaetano G; Cerletti C
    Thromb Haemost; 2008 Jun; 99(6):1129-31. PubMed ID: 18521524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines for cardiovascular prevention in diabetic patients].
    ; ; ; ; ; ; ; ;
    Ital Heart J Suppl; 2002 Jun; 3(6):669-76. PubMed ID: 12120625
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring oral antiplatelet therapy: is it justified?
    Ang L; Mahmud E
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in antiplatelet therapy for cardiovascular disease.
    Martinez A
    JAAPA; 2004 Mar; 17(3):16-20, 23-4; quiz 51-2. PubMed ID: 15314880
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H; Roukoz B; Surabhi SK; Cohen M
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelets and heart disease: how much more can basic science influence clinical practice?].
    Flores NA
    Arch Inst Cardiol Mex; 2000; 70(3):213-8. PubMed ID: 10959451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.